Vegf-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 48, 2014, Pages 17272-17277

  Guaiquil, Victor H ^a,b   Pan, Zan ^a   Karagianni, Natalia ^a   Fukuoka, Shima ^c   Alegre, Gemstonn ^a   Rosenblatt, Mark I ^b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c TOKYO KYOSAI HOSPITAL   (Japan)

Author keywords

Cornea; Nerve injury; Neuronal growth; VEGF B

Indexed keywords

ANIMALIA; MUS;

NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1;

ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CORNEA; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENETICS; INNERVATION; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; NERVE REGENERATION; NEURITE; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PERIPHERAL NERVE INJURY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRIGEMINUS GANGLION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CORNEA; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NERVE REGENERATION; NEURITES; NEURONS; PERIPHERAL NERVE INJURIES; PERIPHERAL NERVES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRIGEMINAL GANGLION; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 85047697187     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1407227111     Document Type: Article

References (32)

1. Bosse F (2012) Extrinsic cellular and molecular mediators of peripheral axonal regeneration. Cell Tissue Res 349(1):5-14.
2. Carmeliet P, Ruiz de Almodovar C (2013) VEGF ligands and receptors: Implications in neurodevelopment and neurodegeneration. Cell Mol Life Sci 70(10):1763-1778.
3. Licht T, Keshet E (2013) Delineating multiple functions of VEGF-A in the adult brain. Cell Mol Life Sci 70(10):1727-1737.
4. Mackenzie F, Ruhrberg C (2012) Diverse roles for VEGF-A in the nervous system. Development 139(8):1371-1380.
5. Li X, Kumar A, Zhang F, Lee C, Tang Z (2012) Complicated life, complicated VEGF-B. Trends Mol Med 18(2):119-127.
6. Dhondt J, et al. (2011) Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons. FASEB J 25(5):1461-1473.
7. Li Y, et al. (2008) VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 118(3):913-923.
8. Sun Y, et al. (2004) Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice. J Cereb Blood Flow Metab 24(10):1146-1152.
9. Greenberg DA, Jin K (2013) Vascular endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci 70(10):1753-1761.
10. Falk T, et al. (2011) Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. Neurosci Lett 496(1):43-47.
11. Poesen K, et al. (2008) Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci 28(42): 10451-10459.
12. Pan Z, Fukuoka S, Karagianni N, Guaiquil VH, Rosenblatt MI (2013) Vascular endothelial growth factor promotes anatomical and functional recovery of injured peripheral nerves in the avascular cornea. FASEB J 27(7):2756-2767.
13. Fournier NM, Lee B, Banasr M, Elsayed M, Duman RS (2012) Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling. Neuropharmacology 63(4):642-652.
14. Kilic E, et al. (2006) The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 20(8):1185-1187.
15. Campbell RJ, Bell CM, Campbell EdeL, Gill SS (2013) Systemic effects of intravitreal vascular endothelial growth factor inhibitors. Curr Opin Ophthalmol 24(3):197-204.
16. Miller JW, Le Couter J, Strauss EC, Ferrara N (2013) Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120(1):106-114.
17. Waldner MJ, Neurath MF (2012) Targeting the VEGF signaling pathway in cancer therapy. Expert Opin Ther Targets 16(1):5-13.
18. Crawford Y, Ferrara N (2009) VEGF inhibition: Insights from preclinical and clinical studies. Cell Tissue Res 335(1):261-269.
19. Nash AD, Baca M, Wright C, Scotney PD (2006) The biology of vascular endothelial growth factor-B (VEGF-B). Pulm Pharmacol Ther 19(1):61-69.
20. Sun Y, et al. (2006) Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: Evidence from knockout mice and growth factor administration. Dev Biol 289(2):329-335.
21. Bonini SA, Ferrari-Toninelli G, Montinaro M, Memo M (2013) Notch signalling in adult neurons: A potential target for microtubule stabilization. Ther Adv Neurol Disord 6(6):375-385.
22. Hiester BG, Galati DF, Salinas PC, Jones KR (2013) Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation. Mol Cell Neurosci 56:115-127.
23. Elizalde C, et al. (2011) Distinct roles for Wnt-4 and Wnt-11 during retinoic acidinduced neuronal differentiation. Stem Cells 29(1):141-153.
24. Rocha SF, et al. (2014) Esm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability. Circ Res 115(6):581-90.
25. Cheng B, Chen J, Bai B, Xin Q (2012) Neuroprotection of apelin and its signaling pathway. Peptides 37(1):171-173.
26. Cook DR, et al. (2011) NMDA receptor modulation by the neuropeptide apelin: Implications for excitotoxic injury. J Neurochem 118(6):1113-1123.
27. Boer K, et al. (2008) Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol 115(6):683-696.
28. Xie L, Mao X, Jin K, Greenberg DA (2013) Vascular endothelial growth factor-B expression in postischemic rat brain. Vasc Cell 5(1):8.
29. Aase K, et al. (2001) Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation 104(3):358-364.
30. Bellomo D, et al. (2000) Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 86(2):E29-E35.
31. Mould AW, et al. (2003) Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum 48(9):2660-2669.
32. Rogers MS, Birsner AE, D'Amato RJ (2007) The mouse cornea micropocket angiogenesis assay. Nat Protoc 2(10):2545-2550.